Register      Login
Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective
RESEARCH ARTICLE

Using epidemiological and molecular methods to investigate an outbreak of gonorrhoea associated with heterosexual contact in Newcastle, NSW, Australia

Kerry Todd A E , David Durrheim A D , Robert Pickles B , Keith Eastwood A , Tony Merritt A , John Tapsall C , Sanghamitra Ray C and Athena Limnios C
+ Author Affiliations
- Author Affiliations

A Hunter New England Population Health, Hunter New England Area Health Service, NSW 2305, Australia.

B Immunology and Infectious Diseases and Sexual Health Services, Hunter New England Area Health Service, NSW 2305, Australia.

C South Eastern Area Laboratory Service, Sydney, NSW 2000, Australia.

D School of Medicine and Public Health, University of Newcastle, Callaghan, NSW 2308, Australia.

E Corresponding author. Email: kerry.todd@hnehealth.nsw.gov.au

Sexual Health 4(4) 233-236 https://doi.org/10.1071/SH07037
Submitted: 30 May 2007  Accepted: 20 August 2007   Published: 28 September 2007

Abstract

Background: We report a cluster of gonorrhoea among mainly heterosexual men that occurred in October 2005, which was first identified when routine weekly surveillance review procedures indicated a three-fold increase in reporting rates compared with historical data. Methods: Each case was followed up with the treating medical officer to review treatment regimes and risk exposures, and to carry out enhanced contact tracing. The phenotype and genotype of the outbreak gonococcal isolates and gonococci prevalent in the months preceding and following the cluster were determined. Links between cases reported from the local Sexual Health Clinic and those reported by general practitioners were established. Results: Laboratory data indicated that a particular gonococcal subtype (ST 225 and NR/Brpyst) was prevalent during the outbreak. Conclusions: Gonorrhoea rates returned to pre-outbreak levels following a targeted health promotion intervention with no further cases of the outbreak subtype detected.

Additional keywords: genotyping, Neisseria gonorrhoeae, Neisseria gonorrhoeae phenotyping, sex-industry workers.


Acknowledgements

The authors thank the following laboratories, Hunter Area Pathology Services, Mayne Laverty, Gribbles Pathology and Sydney Diagnostic Services, for notifying gonorrhoea diagnoses and referring gonococcal isolates to the Neisseria Reference Laboratory – South Eastern Area Laboratory Service, Sydney, NSW.


References


[1] Public Health Act 1991 (NSW). Sydney: Australasian Legal Information Institute. Available online at: http://www.austlii.edu.au/au/legis/nsw/consol_act/pha1991126/s51.html [verified 9 May 2007].

[2] New South Wales Health. Notifiable diseases manual. North Sydney: NSW Health; September 2004. http://www.health.nsw.gov.au/infect/diseases.html [verified 9 May 2007].

[3] SAS Institute. SAS Version 8. Cary, NC: SAS Institute; 2000.

[4] Limnios EA,  Nguyen N-L,  Ray S,  McIver CJ,  Tapsall JW. Dynamics of appearance and expansion of a prolyliminopeptidase-negative subtype among Neisseria gonorrhoeae isolates collected in Sydney, Australia, from 2002 to 2005. J Clin Microbiol 2006; 44 1400–4.
Crossref | GoogleScholarGoogle Scholar | PubMed |

[5] Smith DW,  Tapsall JW,  Lum G. Guidelines for the use and interpretation of nucleic acid detection tests for Neisseria gonorrhoea in Australia: a position paper on behalf of the Public Health Laboratory Network. Commun Dis Intell 2005; 29 358–65.
PubMed |

[6] Martin IM,  Ison CA,  Aanensen DM,  Fenton KA,  Spratt BG. Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. J Infect Dis 2004; 189 1497–505.
Crossref | GoogleScholarGoogle Scholar | PubMed |

[7] Hallqvist L,  Lindgren S. Gonorrhoea of the throat at a venereological clinic. Incidence and results of treatment. Brit J Vener Dis 1975; 51 395–7.


[8] Fredlund H,  Falk L,  Jurstrand M,  Unemo M. Molecular genetic methods of Chlamydia trachomatis and Neisseria gonorrhoeae: impact on epidemiological surveillance and interventions. APMIS 2004; 112 771–84.
Crossref | GoogleScholarGoogle Scholar | PubMed |

[9] Bauer HM,  Mark KE,  Samuel M,  Wang SA,  Weismuller P,  Moore D, et al. Prevalence of and associated risk factors for fluoroquinolone-resistant Neisseria gonorrhoeae in California, 2002–2003. Clin Infect Dis 2005; 41 795–803.
Crossref | GoogleScholarGoogle Scholar | PubMed |

[10] Tapsall J,  Whiley D,  Sloots T. Applications of molecular testing in clinical laboratories for the diagnosis and control of gonorrhoea. Future Microbiol 2006; 1 317–24.
Crossref | GoogleScholarGoogle Scholar | PubMed |

[11] Kolader ME,  Dukers NHTM,  van der Bij AK,  Dierdorp M,  Fennema JSA,  Coutinho RA, et al. Molecular epidemiology of Neisseria gonorrhoeae in Amsterdam, The Netherlands, shows distinct heterosexual and homosexual networks. J Clin Microbiol 2006; 44 2689–97.
Crossref | GoogleScholarGoogle Scholar | PubMed |

[12] Choudhury B,  Risley CL,  Ghani AC,  Bishop CJ,  Ward H,  Fenton KA, et al. Identification of individuals with gonorrhoea within sexual networks: a population-based study. Lancet 2006; 368 139–46.
Crossref | GoogleScholarGoogle Scholar | PubMed |

[13] Hoffman SH , Lambertsen L , Berthelsen L , Cowan S . Neisseria gonorrhoea with increased ceftriaxone MIC in Denmark 2004: Bi-locus sequence typing, serotyping, and sexual orientation. International Society for Sexually Transmitted Disease Research 16th Meeting; 2005 July 10–13; Amsterdam, The Netherlands. Abstract WP-035.

[14] Whiley DM,  Limnios EA,  Ray S,  Sloots TP,  Tapsall JW. Diversity of penA alterations and subtypes in Neisseria gonorrhoea less susceptible to ceftriaxone from Sydney, Australia. Antimicrob Agents Chemother 2007; 51 3111–16.
Crossref | GoogleScholarGoogle Scholar | PubMed |